Cardiovascular response to exercise during atrial fibrillation and after conversion to sinus rhythm

Newer developments in the management of atrial fibrillation

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice. Unlike reentrant supraventricular tachycardia and malignant ventricular tachyarrhythmias, for which highly effective and safe nonpharmacologic therapies are available, the treatment of AF remains controversial and often problematic. Whereas electrical cardioversion restores sinus rhythm in most patients with AF, the maintenance of sinus rhythm often requires membrane-active antiarrhythmic drugs that may increase mortality by inducing ventricular proarrhythmia. The control of ventricular response rate, often associated with oral anticoagulation to prevent thromboembolic complications, is an alternative strategy in AF management. The relative efficacy and risks of these strategies and their respective role in different patient subgroups remain to be established. This article focuses on newer developments in the management of AF, including prospects for improved methods to maintain sinus rhythm, newer approaches to rate control, controversies regarding the use of oral anticoagulation, and novel nonpharmacologic therapies. These newer developments may lead over the next 10 years to a revolution in the management of AF as profound as that produced over the last 10 years by nonpharmacologic therapy of other arrhythmias.

Absence of atrial contraction and exercise in patients with isolated atrial fibrillation

The aim of the study was to assess the effect of absence of atrial contraction during exercise. During the incremental ergometer exercise tests, heart rate, oxygen uptake, and oxygen pulse in patients with isolated atrial fibrillation were compared with those in control subjects at rest, at the exercise level of gas exchange anaerobic threshold, and at peak exercise. The study population consisted of 51 subjects aged 40 years or more: 12 patients with isolated atrial fibrillation and 39 control subjects with normal sinus rhythm. Heart rate in control subjects was lower than that in patients with isolated atrial fibrillation, at rest, anaerobic threshold, and peak exercise (74 +/- 12 vs 85 +/- 8 beats/min at rest, 108 +/- 16 vs 134 +/- 18 beats/min at anaerobic threshold, and 151 +/- 16 vs 173 +/- 22 beats/min at peak exercise, all p less than 0.01). During exercise, oxygen uptake in patients with isolated atrial fibrillation was not significantly different from that in control subjects. Oxygen pulse in patients with isolated atrial fibrillation was lower than that in control subjects during exercise (6.45 +/- 2.04 vs 7.84 +/- 1.63 ml/beat at anaerobic threshold, 7.79 +/- 2.28 vs 9.16 +/- 1.79 ml/beat at peak exercise, both p less than 0.05). In patients with isolated atrial fibrillation, the oxygen pulse might be reduced due to the lack of atrial contraction during exercise. However, the oxygen uptake that represents the exercise capacity would be preserved with the increase in heart rate.

Effect of experimentally induced atrial fibrillation on coronary circulation in dogs

The influence of atrial fibrillation on coronary circulation was studied in 21 anesthetized open-chest dogs. Atrial fibrillation was induced either by local application of acetylcholine (10% in normal saline) on the left atrial appendage or by electric stimulation (2-7 volts, 2 ms, 50 Hz). When atrial fibrillation was induced (n = 10), mean aortic pressure fell and heart rate rose significantly; coronary blood flow (CBF) remained unchanged (78 +/- 6 vs. 75 +/- 5 ml/min X 100 g) while coronary vascular resistance (CVR) (1.16 +/- 0.05 vs. 0.87 +/- 0.07 [m Hg X min X 100 gl/ml [RU], p less than 0.0001) and sinus oxygen saturation (26 +/- 2 vs. 22 +/- 1%, p less than 0.05) decreased. Following the application of carbochromen (5 mg/kg in 3 min i.v.) resulting in maximal coronary dilatation, atrial fibrillation resulted in a reduction in CBF (311 +/- 48 vs. 205 +/- 30 ml/min X 100 g, p less than 0.01) and coronary sinus oxygen saturation (65 +/- 6 vs. 42 +/- 6%, p less than 0.01), while CVR (0.27 +/- 0.03 vs. 0.37 +/- 0.04 RU, p less than 0.0001) was 38 +/- 8% (p less than 0.0005) higher during atrial fibrillation than at sinus rhythm. When hearts were paced to a rate which was identical to the average heart rate at atrial fibrillation (n = 11), CBF (92 vs. 125 +/- 14 ml/min X 100 g, p less than 0.001) and sinus oxygen saturation (24 +/- 2 vs. 30 +/- 2%, p less than 0.0025) were higher and CVR (1.16 +/- 0.11 vs. 0.97 +/- 0.10 RU, p less than 0.0005) lower than during atrial fibrillation; during maximal coronary dilatation by carbochromen, pacing also resulted in a higher CBF (233 +/- 24 vs. 168 +/- 16 ml/min X 100 g, p less than 0.0005) and sinus oxygen saturation (70 +/- 3 vs. 57 +/- 2%, p less than 0.0005), while CVR (0.25 +/- 0.02 vs. 0.46 +/- 0.02 RU, p less than 0.0005) was lower than during atrial fibrillation. Thus atrial fibrillation results in a decrease in coronary vascular resistance but an increase in coronary oxygen extraction. When heart rate is controlled, the vasoconstrictor effect of atrial fibrillation becomes unmasked. Coronary vasoconstriction during atrial fibrillation appears to be greater during maximal coronary dilatation than during control.

Atrial fibrillation and hyperthyroidism: a new look at their relationship and therapy with lidoflazine

Various kinds of dysrhythmias are found in association with hyperthyroidism but especially atrial fibrillation. The causal relationship of chronic atrial fibrillation and the endocrine disorder is controversial, as is its therapeutic management. Six patients with this particular combination of disorders were treated with lidoflazine: a new anti-anginal drug with anti-arrhythmic activity. All six patients returned to sinus rhythm on lidoflazine treatment although still hyperthyroid and remained in sinus rhythm during the follow up period ranging from 5 to 14 months. This occurred independently of antithyroid treatment. Some evidence is put forward that dysrhythmias and most commonly chronic atrial fibrillation are triggered off by hyperthyroidism or other disorders but that they are maintained by permanent cardiac damage due to arteriosclerosis, hypertension, coronary heart disease or rheumatic valve disease.

Successful chemical cardioversions and maintenance of sinus rhythm can be obtained independent of the thyroid function. Our results confirm the anti-arrhythmic activity of lidoflazine.

Refractory supraventricular tachycardias

This essay is designed to review some of the basic and more recent contributions to our understanding of supraventricular tachyarrhythmias, their mechanisms, pertinent points in diagnosis, and treatment. Supraventricular tachycardia is discussed under the concept of reentrant mechanisms versus accelerated ectopic pacemakers. Atrial fibrillation and flutter, multifocal atrial tachycardia, supraventricular tachyarrhythmias associated with brady-tachy syndrome, and supra-ventricular tachycardias in ventricular preexcitation are likewise discussed. An outline of the different forms of therapy for refractory supraventricular tachyarrhythmias is provided.

Hemodynamic sequelae of cardiac arrhythmias

The hemodynamic consequences of cardiac arrhythmias depend on various factors, including the ventricular rate and the duration of the abnormal rate, the temporal relationship between atrial and ventricular activity, the sequence of ventricular activation, the functional state of the heart, the irregularity of the cycle length, associated drug therapy, the peripheral vascular vasomotor system, disease in organ systems other than the heart, and the degree of anxiety caused by the disease processes. Sinus bradycardia, even with rates as low as 40 beats/min, may not be associated with significant hemodynamic consequences unless the stroke volume is limited by myocardial or valvular disease, as in acute myocardial infarction. Cardiac output usually, but not invariably, falls when atrial fibrillation replaces normal sinus rhythm, even at comparable ventricular rates, both at rest and during exercise. Similar observations have been made during the development of atrial flutter despite the persistence of effective mechanical atrial activity in at least some cases. Marked hemodynamic changes are frequent in the course of ventricular tachycardia with systemic arterial hypotension, a decrease in cardiac output, and evidence of cerebral, coronary, and renal vascular insufficiency. Cyclic variations in systemic and pulmonary arterial pressures are common during atrioventricular dissociation. Cardiac output is generally depressed during the severe bradycardia of acquired complete heart block with evidence of atrioventricular valvular insufficiency. Increase of the heart rate by ventricular pacing reverses all or some of these abnormalities. The changes in congenital complete heart block are considerably less severe because myocardial insufficiency is less frequently seen in congenital complete heart block.

The role of left atrial transport in aortic and mitral stenosis

The relationship of left atrial contraction to ventricular filling was studied in 24 patients. Eight patients had aortic stenosis, eight had mitral stenosis, and eight others served as a control group. All had normal sinus rhythm. Cineangiocardiographic volumetric determinations of the left ventricle were done throughout the cardiac cycle, and the rate of left ventricular filling before and during left atrial contraction was calculated.

In the group with aortic stenosis 39% of the left ventricular stroke volume entered the ventricle during left atrial contraction; in the group with mitral stenosis 24% was contributed during left atrial contraction, and in the control patients, 26%.

The rate of left ventricular filling more than doubled during left atrial contraction in aortic stenosis, while no consistent change in the rate of filling occurred during left atrial contraction in mitral stenosis and in the control group.

The character of the resistance to left ventricular filling in aortic stenosis and mitral stenosis is discussed. An important contribution by left atrial contraction to left ventricular performance in aortic stenosis is suggested.

Effects of atrial fibrillation on exercise performance in patients with cardiac disease

Cardiac performance in 25 male and 40 female cardiac patients with atrial fibrillation was compared with that of age, sex, and function-matched controls with sinus rhythm. All had rheumatic valvular heart disease treated with digitalis. Multistage maximal exercise was tested on a motor-driven treadmill with increasing work loads every 3 minutes to the limits of fatigue.

Mean heart rates of patients with atrial fibrillation were greater at rest, at all levels of exercise, and immediately after it regardless of sex or anatomic lesion; however, recovery heart rate was significantly higher in the males than in the females with sinus rhythm.

As is true for normals, mean duration and intensity of exercise was greater in male than in female cardiac patients regardless of rhythm or anatomic lesion.

Haemodynamic studies before and after electrical conversion of atrial fibrillation and flutter to sinus rhythm

Images